XPOF vs CURV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 21, 2026

XPOF

32.1
AI Score
VS
CURV Wins

CURV

46.8
AI Score

Investment Advisor Scores

XPOF

32score
Recommendation
AVOID NEW MONEY

CURV

47score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric XPOF CURV Winner
Forward P/E 10 1.9205 CURV
PEG Ratio 0 0 Tie
Revenue Growth -13.4% -11.8% CURV
Earnings Growth -81.7% 227.0% CURV
Tradestie Score 32.1/100 46.8/100 CURV
Profit Margin -14.8% -0.9% CURV
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD CURV

Relative Price Performance (Last 90 Days)

XPOF 1M: +15.3% · 3M: -32.5% CURV 1M: -10.3% · 3M: -13.9%

Current Technical Phase

XPOF

Markdown
Sell / avoid

Price below a falling SMA50 (slope -12.5%), weak momentum, RSI 40

RSI (14): 39.8 · Price: $4.27

CURV

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.1%), weak momentum, RSI 40

RSI (14): 39.8 · Price: $2.14

Fundamentals Snapshot

Metric XPOF CURV
Market Cap — —
Forward P/E 6.6 -38.6
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.1% -0.1%
Gross Margin 0.7% 0.3%
Operating Margin 0.2% 0.0%
EPS -1.49 -0.08
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CURV is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.